ResearcherUniversity of Campania "Luigi Vanvitelli"No recent work listed
Jole Ventriglia
Matched on ORCID iD 0000-0002-8160-5014; OpenAlex author ID A5019880542. Sources: OpenAlex.
Their work
- Papers
- 2 (first author 1, last author 0)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 10
2016: 1 paper · 2017: none · 2018: 1 paper
Papers 2
- Neutrophil to Lymphocyte Ratio as a Predictor of Poor Prognosis in Metastatic Pancreatic Cancer Patients Treated with Nab-Paclitaxel plus Gemcitabine: A Propen… Co-author DOI 10.1155/2018/2373868↗
- NAB-paclitaxel and gemcitabine in metastatic pancreatic ductal adenocarcinoma (PDAC): from clinical trials to clinical practice. First author DOI 10.1186/s12885-016-2671-9↗
Closest collaborators
The 10 strongest of 10 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Angelica Petrillo · 2 shared papers, 2016–2018 · strength 0.12
- Paper Neutrophil to Lymphocyte Ratio as a Predictor of Poor Prognosis in Metastatic Pancreatic Cancer Patients Treated with N… DOI 10.1155/2018/2373868↗
- Paper NAB-paclitaxel and gemcitabine in metastatic pancreatic ductal adenocarcinoma (PDAC): from clinical trials to clinical … DOI 10.1186/s12885-016-2671-9↗
- Teresa Troiani · 2 shared papers, 2016–2018 · strength 0.12
- Paper Neutrophil to Lymphocyte Ratio as a Predictor of Poor Prognosis in Metastatic Pancreatic Cancer Patients Treated with N… DOI 10.1155/2018/2373868↗
- Paper NAB-paclitaxel and gemcitabine in metastatic pancreatic ductal adenocarcinoma (PDAC): from clinical trials to clinical … DOI 10.1186/s12885-016-2671-9↗
- Ferdinando De Vita · 2 shared papers, 2016–2018 · strength 0.12
- Paper Neutrophil to Lymphocyte Ratio as a Predictor of Poor Prognosis in Metastatic Pancreatic Cancer Patients Treated with N… DOI 10.1155/2018/2373868↗
- Paper NAB-paclitaxel and gemcitabine in metastatic pancreatic ductal adenocarcinoma (PDAC): from clinical trials to clinical … DOI 10.1186/s12885-016-2671-9↗
- Michele Orditura · 2 shared papers, 2016–2018 · strength 0.12
- Paper Neutrophil to Lymphocyte Ratio as a Predictor of Poor Prognosis in Metastatic Pancreatic Cancer Patients Treated with N… DOI 10.1155/2018/2373868↗
- Paper NAB-paclitaxel and gemcitabine in metastatic pancreatic ductal adenocarcinoma (PDAC): from clinical trials to clinical … DOI 10.1186/s12885-016-2671-9↗
- Luca Pompella · 1 shared paper, 2018 · strength 0.07
- Marisol Huerta · 1 shared paper, 2018 · strength 0.07
- Floriana Morgillo · 1 shared paper, 2018 · strength 0.07
- Andrès M.R. Cervantes · 1 shared paper, 2018 · strength 0.07
- Fortunato Ciardiello · 1 shared paper, 2016 · strength 0.05
- Guido Giordano · 1 shared paper, 2016 · strength 0.05
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.